Print

Cholesterol-Drug Developer Aegerion Pharmaceuticals, Inc. Revives Plan for $86.3M IPO  
8/11/2010 7:10:01 AM

Wall Street Journal -- Aegerion Pharmaceuticals Inc. re-registered to hold an $86.3 million initial public offering of shares, after abandoning a similar plan as the stock-market plunged in late 2008.
//-->